Literature DB >> 27473309

Solubility, lipophilicity and membrane permeability of some fluoroquinolone antimicrobials.

Svetlana V Blokhina1, Angelica V Sharapova2, Marina V Ol'khovich1, Тatyana V Volkova1, German L Perlovich1.   

Abstract

Aqueous solubility and distribution of ciprofloxacin, enrofloxacin, norfloxacin and levofloxacin antimicrobials drugs in octanol/buffer system has been measured by the isothermal saturation method using buffer solutions pH2.0 and 7.4 in the temperature range of 293.15-313.15K. Thermophysical characteristics for the compounds have been determined by the DSC method. It has been established that the solubility of levofloxacin in these buffers is higher than that of the other fluoroquinolones. HYBOT descriptors for biologically active compounds have been calculated and the impact of the donor-acceptor capacity of the molecules on drugs solubility has been studied. According to the lipophilicity parameter fluoroquinolones are ranged in the following order: enrofloxacin>levofloxacin>ciprofloxacin>norfloxacin. The thermodynamic solubility and distribution functions of the studied compounds have been obtained. The permeability coefficients of the substances through an artificial phospholipid membrane were determined. The drugs with a lower aqueous solubility were estimated to have higher distribution coefficients and membrane permeability.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ciprofloxacin (PubChem CID: 2764); Distribution octanol/buffer; Enrofloxacin (PubChem CID: 71188); Fluoroquinolones; Levofloxacin (PubChem CID: 149096); Membrane permeability; Norfloxacin (PubChem CID: 4539); Solubility; Thermodynamics

Mesh:

Substances:

Year:  2016        PMID: 27473309     DOI: 10.1016/j.ejps.2016.07.016

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain.

Authors:  Laura Perissinotti; Jiqing Guo; Meruyert Kudaibergenova; James Lees-Miller; Marina Ol'khovich; Angelica Sharapova; German L Perlovich; Daniel A Muruve; Brenda Gerull; Sergei Yu Noskov; Henry J Duff
Journal:  Mol Pharmacol       Date:  2019-06-10       Impact factor: 4.436

2.  Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.

Authors:  Kaixiang Zhou; Meixia Huo; Wenjin Ma; Kun Mi; Xiangyue Xu; Samah Attia Algharib; Shuyu Xie; Lingli Huang
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

3.  Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses.

Authors:  Hanah Mesallati; Anita Umerska; Lidia Tajber
Journal:  Pharmaceutics       Date:  2019-06-09       Impact factor: 6.321

Review 4.  Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones.

Authors:  Julien Brillault; Frédéric Tewes
Journal:  Pharmaceutics       Date:  2020-04-23       Impact factor: 6.321

5.  AB-DB: Force-Field parameters, MD trajectories, QM-based data, and Descriptors of Antimicrobials.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Sci Data       Date:  2022-04-01       Impact factor: 6.444

Review 6.  Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.

Authors:  Ioana-Andreea Lungu; Octavia-Laura Moldovan; Victoria Biriș; Aura Rusu
Journal:  Pharmaceutics       Date:  2022-08-22       Impact factor: 6.525

7.  The EDA-deficient mouse has Zymbal's gland hypoplasia and acute otitis externa.

Authors:  Jorge Del-Pozo; Denis J Headon; James D Glover; Ali Azar; Sonia Schuepbach-Mallepell; Mahmood F Bhutta; Jon Riddell; Scott Maxwell; Elspeth Milne; Pascal Schneider; Michael Cheeseman
Journal:  Dis Model Mech       Date:  2022-03-30       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.